Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 48 (3) , 195-203
- https://doi.org/10.1016/0021-9150(83)90038-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley ratsAtherosclerosis, 1980
- The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme—A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicksAtherosclerosis, 1980
- Treating lipid disordersAmerican Heart Journal, 1979
- Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver dose-response relationsAtherosclerosis, 1979
- Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liverAtherosclerosis, 1978
- Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A ReductaseEuropean Journal of Biochemistry, 1977
- The influence of 1,1-bis[4′-(1′-carboxy-1′-methylpropoxy)-phenyl]cyclohexane (a new aryloxy compound, S-8527) on cholesterol metabolism in ratsAtherosclerosis, 1973
- Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liverJournal of Lipid Research, 1965